| I AM A FIGHTER! |
|
| My first day of work will always stand out. I was welcomed with open arms by both the other providers and the patients.... [more] |
|
|
|
Gilead Quad/Atripla Study
|
|
Enrollment Status: Open |
|
Return to Research Trials
|
| |
| |
| Description |
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults (Open for enrollment) |
| |
|
|
|
This site contains HIV prevention messages that may not be appropriate for all audiences. Fight.org presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
FIGHT is a Pennsylvania non-profit corporation, and is recognized by the IRS as a 501 (c) (3) non-profit.
|
